Pharmhouse Corp
Pride Holdings Group operates as a LGBTQ-focused entertainment, hospitality, and lifestyle company in the United States. It engages in the bar, pub, tavern, restaurant, hotels, nightclubs, and live adult entertainment industry businesses. The company was formerly known as Parliament House Enterprises, Inc. and changed its name to Pride Holdings Group in July 2025. Pride Holdings Group is based in… Read more
Pharmhouse Corp (PHSE) - Total Liabilities
Latest total liabilities as of September 2025: $2.12 Million USD
Based on the latest financial reports, Pharmhouse Corp (PHSE) has total liabilities worth $2.12 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Pharmhouse Corp - Total Liabilities Trend (1996–2024)
This chart illustrates how Pharmhouse Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Pharmhouse Corp Competitors by Total Liabilities
The table below lists competitors of Pharmhouse Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Nexus Infrastructure plc
LSE:NEXS
|
UK | GBX24.35 Million |
|
Angus Energy PLC
LSE:ANGS
|
UK | GBX43.27 Million |
|
RUBICN RES
BE:D9V
|
Germany | €2.63 Million |
Liability Composition Analysis (1996–2024)
This chart breaks down Pharmhouse Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.24 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pharmhouse Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pharmhouse Corp (1996–2024)
The table below shows the annual total liabilities of Pharmhouse Corp from 1996 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $1.72 Million | +378.71% |
| 2023-12-31 | $358.92K | -9.06% |
| 2022-12-31 | $394.66K | +207.21% |
| 2021-12-31 | $128.47K | -52.67% |
| 2020-12-31 | $271.45K | +596.03% |
| 2019-12-31 | $39.00K | +1.89% |
| 2018-12-31 | $38.27K | -10.02% |
| 2017-12-31 | $42.54K | +21.22% |
| 2015-12-31 | $35.09K | +76788.69% |
| 2014-12-31 | $45.64 | -100.00% |
| 1998-12-31 | $2.88 Million | -43.94% |
| 1997-12-31 | $5.13 Million | -5.56% |
| 1996-12-31 | $5.43 Million | -- |